questions about the safety of Multaq (dronedarone) for atrial fibrillation

February 2011

Please see the July 2011 FDA warning concerning Multaq and an increased risk of serious adverse events

New concerns are raising questions about the safety of Multaq (dronedarone) for atrial fibrillation.

This is especially important since the most recent guidelines recommend Multaq before amiodarone for A fib in many cases.

Multaq is less effective than amiodarone...but it SEEMED safer.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote